GeorgePaikKimMD

Oncology • Gainesville, FL

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
1600 SW Archer Rd
Gainesville, FL 32610
Phone+1 352-273-7832

Fax+1 352-273-7849

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
University of Vermont College of MedicineClass of 1994

Certifications & Licensure

FL State Medical License 2002 - 2026
TX State Medical License 2023 - 2025
DC State Medical License 2018 - 2022
MD State Medical License 1997 - 2002
American Board of Internal Medicine Medical Oncology

Clinical Trials

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) Start of enrollment: 2005 Apr 01
Completed
Phase 2
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2004 Dec 01
Completed
Phase 2
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2005 Jul 01
Completed
Phase 2
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Start of enrollment: 2005 Jun 01
Completed
Phase 2
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer Start of enrollment: 2009 Mar 01
Completed
Phase 2
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery Start of enrollment: 2009 Jun 01
Completed
Phase 2
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg
Endocrine-Related Cancer. 2023-11-01
2 citations
Real-world safety and supportive care use of second-line 5-fluorouracil-based regimens among patients with metastatic pancreatic ductal adenocarcinoma.
George Kim, Paul Cockrum, Andy Surinach, Shu Wang, Zev Wainberg
Current Medical Research and Opinion. 2022-08-01
1 citations
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, Michael G Haddock, Shaker R Dakhil
The Oncologist. 2022-07-05

Professional Memberships

American Society of Clinical Oncology - ASCO
Member